Weight-loss medications
Ozempic is only available on the NHS for type 2 diabetes, not weight loss. Wegovy and Mounjaro are the UK's licensed weight-loss injections.
Weight-loss medications
You can't get the Wegovy pill on the NHS yet. It's UK-approved, but NHS funding needs a NICE decision, most likely in 2028.
Weight-loss medications
Average weight loss on Mounjaro, Wegovy and the pill runs from 13.6% to 20.9%, but your result depends on you. Compare yours with the trials, free.
Weight-loss medications
You can take the Wegovy pill with levothyroxine, but not together. Take the pill, wait 30 minutes, then levothyroxine, or move it to bedtime.
Weight-loss medications
The Wegovy pill, oral semaglutide, produces around 13.6% average weight loss, similar to the 2.4 mg injection but less than Mounjaro or the 7.2 mg dose.
Weight-loss medications
Foundayo (orforglipron) is a daily GLP-1 pill for weight loss with no fasting requirements. FDA-approved April 2026. Average weight loss 11.2% at 72 weeks.
Weight-loss medications
Mounjaro alternatives UK: Compare Wegovy, the Wegovy pill, Saxenda, and Orlistat. Includes clinical trial data, side effects, and pricing.
Weight-loss medications
You can switch from Mounjaro (tirzepatide) to Wegovy (semaglutide) under medical supervision. Learn how to do it safely without impacting progress here.
Weight-loss medications
The Wegovy pill and Rybelsus are the same drug in tablet form, but the 25 mg Wegovy pill is licensed for weight loss and Rybelsus is diabetes-only.
Weight-loss medications
Mounjaro produced more weight loss in trials, 22.5% vs 13.6% for the Wegovy pill, but the pill avoids the weekly injection. Learn how they compare.